- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有269家主力机构披露2024-12-31报告期持股数据，持仓量总计3.95亿股，占流通A股57.72%
- 波段诊断：
-
技术面诊股
诊断结果：3.0技术面打败了28%的股票
技术面评分前10的股票
近期的平均成本为18.17元。
平均成本
近期的平均成本为18.17元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.17","date":1751356273,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.07.02","stock":"0.50","trade":"-1.57","ind":"-0.61"},{"date":"2025.07.01","stock":"-0.17","trade":"2.52","ind":"0.11"},{"date":"2025.06.30","stock":"-0.77","trade":"1.47","ind":"0.83"},{"date":"2025.06.27","stock":"-1.77","trade":"0.85","ind":"0.34"},{"date":"2025.06.26","stock":"0.16","trade":"-1.31","ind":"-0.48"},{"date":"2025.06.25","stock":"-0.16","trade":"0.29","ind":"1.72"},{"date":"2025.06.24","stock":"1.47","trade":"1.81","ind":"1.68"},{"date":"2025.06.23","stock":"0.11","trade":"1.50","ind":"0.43"},{"date":"2025.06.20","stock":"0.22","trade":"0.27","ind":"-0.47"},{"date":"2025.06.19","stock":"-0.38","trade":"-1.80","ind":"-1.21"},{"date":"2025.06.18","stock":"-2.19","trade":"-1.20","ind":"0.24"},{"date":"2025.06.17","stock":"0.00","trade":"-1.63","ind":"-0.12"},{"date":"2025.06.16","stock":"2.85","trade":"-0.12","ind":"0.41"},{"date":"2025.06.13","stock":"-2.09","trade":"-2.82","ind":"-1.10"},{"date":"2025.06.12","stock":"9.98","trade":"1.54","ind":"-0.11"},{"date":"2025.06.11","stock":"-1.23","trade":"-1.03","ind":"0.83"},{"date":"2025.06.10","stock":"1.06","trade":"1.10","ind":"-0.86"},{"date":"2025.06.09","stock":false,"trade":"2.75","ind":"0.65"},{"date":"2025.06.06","stock":false,"trade":"0.34","ind":"-0.19"},{"date":"2025.06.05","stock":"-1.74","trade":"-1.02","ind":"0.58"},{"date":"2025.06.04","stock":"1.05","trade":"0.26","ind":"0.87"}]
派林生物,深证成指,生物制品指数
压力支撑
该股压力位为18.11元，支撑位为17.91元。
[{"text":"\u538b\u529b\u4f4d","value":"18.11","date":1751385600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"17.91","date":1751385600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.5资金面打败了50%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月02日 20:30
| 机构今日流向(万元) | -2510.04 | 机构5日流向(万元) | -3150.27 |
| 机构10日流向(万元) | -5023.90 | 机构20日流向(万元) | -19061.97 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少6858.66万股，其中基金净减仓15家，主力净减仓117家，请投资者中长期谨慎为宜。
截止2024-12-31，共269家主力机构（一般法人8家，基金260家，券商集合理财1家），持仓量总计39521.28万股，占流通A股57.72%
其中，基金持仓与2024-06-30相比：
增仓：42家 ，增持 971.25万股
减仓：57家 ，减持 2951.31万股
新出现在主力名单中：141家 ，持有3246.25万股
从主力名单中消失：258家 ，原持有8073.35万股
其中，基金持仓与2024-06-30相比：
增仓：42家 ，增持 971.25万股
减仓：57家 ，减持 2951.31万股
新出现在主力名单中：141家 ，持有3246.25万股
从主力名单中消失：258家 ，原持有8073.35万股
消息面诊股
诊断结果：5消息面打败了3%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 派林生物：7月1日获融资买入3879.84万元
2025-07-02 - 派林生物：6月30日获融资买入3539.35万元
2025-07-01 - 派林生物：6月27日获融资买入4124.53万元
2025-06-30 - 血制品龙头派林生物或易主，多个巨头仍未放弃
2025-06-29 - 国药、华润医药接连大动作，专业化整合背后深意在哪里
2025-06-27 - 行业周报|生物制品指数涨3.14%, 跑赢上证指数
2025-06-27 - 派林生物：6月26日获融资买入4152.07万元，
2025-06-27 - 派林生物：6月25日获融资买入5254.96万元
2025-06-26 - 医药行业并购潮涌 龙头企业积极补短板
2025-06-26 - 国药“抢资源”VS华润“拼协同”，央字头药企并购下
2025-06-25
消息列表
| 一般消息 | 资产重组 | 公司股权转让 | 2025-06-10 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-05-12 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-24 |
| 利好 | 分红转增 | 10转3股派3.5元(含税) | 2025-04-24 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2024-10-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.2行业面打败了89%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2025.07.02","price":"-0.61","value":"-1.57"},{"date":"2025.07.01","price":"0.11","value":"2.52"},{"date":"2025.06.30","price":"0.83","value":"1.47"},{"date":"2025.06.27","price":"0.34","value":"0.85"},{"date":"2025.06.26","price":"-0.48","value":"-1.31"},{"date":"2025.06.25","price":"1.72","value":"0.29"},{"date":"2025.06.24","price":"1.68","value":"1.81"},{"date":"2025.06.23","price":"0.43","value":"1.50"},{"date":"2025.06.20","price":"-0.47","value":"0.27"},{"date":"2025.06.19","price":"-1.21","value":"-1.80"},{"date":"2025.06.18","price":"0.24","value":"-1.20"},{"date":"2025.06.17","price":"-0.12","value":"-1.63"},{"date":"2025.06.16","price":"0.41","value":"-0.12"},{"date":"2025.06.13","price":"-1.10","value":"-2.82"},{"date":"2025.06.12","price":"-0.11","value":"1.54"},{"date":"2025.06.11","price":"0.83","value":"-1.03"},{"date":"2025.06.10","price":"-0.86","value":"1.10"},{"date":"2025.06.09","price":"0.65","value":"2.75"},{"date":"2025.06.06","price":"-0.19","value":"0.34"},{"date":"2025.06.05","price":"0.58","value":"-1.02"},{"date":"2025.06.04","price":"0.87","value":"0.26"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 神州细胞 | 42.21% | 7.80% | 5.8分 |
| 2 | 百普赛斯 | 32.13% | 20.91% | 5.9分 |
| 3 | 赛升药业 | 30.26% | 1.86% | 4.6分 |
| 4 | 未名医药 | 19.06% | 8.58% | 4.7分 |
| 5 | 迈威生物 | 17.58% | 13.06% | 4.6分 |
| 6 | *ST四环 | 12.79% | -6.08% | 4.4分 |
| 8 | 康华生物 | 7.50% | -1.81% | 4.9分 |
| 10 | 通化东宝 | 6.86% | 3.32% | 5.6分 |
| 12 | 义翘神州 | 5.80% | 3.06% | 5.4分 |
| 14 | 近岸蛋白 | 5.15% | 7.26% | 4.7分 |
| 16 | 康泰生物 | 3.57% | -1.44% | 4.7分 |
| 18 | 万泽股份 | 3.07% | 6.88% | 6.3分 |
| 20 | 我武生物 | 1.71% | 4.39% | 5.2分 |
| 22 | 诺诚健华 | 1.43% | 4.01% | 4.2分 |
| 24 | 华兰疫苗 | 1.08% | 1.94% | 5.1分 |
| 26 | 天坛生物 | 0.05% | -0.21% | 5.0分 |
| 28 | 甘李药业 | -0.14% | 3.11% | 5.3分 |
| 30 | 百克生物 | -0.62% | 0.29% | 5.0分 |
| 32 | 诺唯赞 | -1.24% | 1.04% | 5.2分 |
| 34 | 康希诺 | -1.88% | -1.49% | 4.2分 |
| 36 | 卫光生物 | -2.26% | 1.72% | 5.2分 |
| 38 | 西藏药业 | -3.28% | -0.25% | 4.8分 |
| 40 | 博雅生物 | -4.54% | -0.92% | 4.8分 |
| 42 | 安科生物 | -4.86% | 2.62% | 5.9分 |
| 44 | 昊帆生物 | -5.74% | 2.40% | 4.7分 |
| 46 | 长春高新 | -8.42% | -0.10% | 5.0分 |
| 48 | 欧林生物 | -10.99% | 0.51% | 5.2分 |
| 50 | *ST双成 | -13.62% | 0.27% | 4.9分 |
| 52 | 科兴制药 | -16.24% | 17.28% | 5.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 25/72 ， 42/72。
[{"date":"2025-03-31","value":"1.12","vol":"0.63"},{"date":"2024-12-31","value":"9.71","vol":"-0.24"},{"date":"2024-09-30","value":"7.11","vol":"1.37"},{"date":"2024-06-30","value":"4.35","vol":"0.72"},{"date":"2024-03-31","value":"1.63","vol":"0.41"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.12 | 9.71 | 7.11 | 4.35 | 1.63 |
| 行业(%) | 0.63 | -0.24 | 1.37 | 0.72 | 0.41 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"48.06","vol":"69.78"},{"date":"2024-12-31","value":"49.13","vol":"69.97"},{"date":"2024-09-30","value":"50.52","vol":"70.57"},{"date":"2024-06-30","value":"50.20","vol":"69.89"},{"date":"2024-03-31","value":"51.42","vol":"70.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
48.06 | 49.13 | 50.52 | 50.20 | 51.42 |
| 行业(%) | 69.78 | 69.97 | 70.57 | 69.89 | 70.42 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 36/72 ， 36/72。
[{"date":"2025-03-31","value":"-14.00","vol":"6246.12"},{"date":"2024-12-31","value":"14.00","vol":"48.20"},{"date":"2024-09-30","value":"37.49","vol":"178.44"},{"date":"2024-06-30","value":"60.23","vol":"19.75"},{"date":"2024-03-31","value":"67.00","vol":"31.66"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-14.00 | 14.00 | 37.49 | 60.23 | 67.00 |
| 行业(%) | 6246.12 | 48.20 | 178.44 | 19.75 | 31.66 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-26.95","vol":"-7.36"},{"date":"2024-12-31","value":"21.76","vol":"-10.38"},{"date":"2024-09-30","value":"66.38","vol":"-53.42"},{"date":"2024-06-30","value":"128.44","vol":"-9.25"},{"date":"2024-03-31","value":"116.31","vol":"-535.57"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-26.95 | 21.76 | 66.38 | 128.44 | 116.31 |
| 行业(%) | -7.36 | -10.38 | -53.42 | -9.25 | -535.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，两项指标的行业排名分别为 36/72 ， 34/72。
[{"date":"2025-03-31","value":"0.04","vol":"0.06"},{"date":"2024-12-31","value":"0.30","vol":"0.29"},{"date":"2024-09-30","value":"0.21","vol":"0.22"},{"date":"2024-06-30","value":"0.13","vol":"0.14"},{"date":"2024-03-31","value":"0.05","vol":"0.07"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.04 | 0.30 | 0.21 | 0.13 | 0.05 |
| 行业(次) | 0.06 | 0.29 | 0.22 | 0.14 | 0.07 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.15","vol":"0.26"},{"date":"2024-12-31","value":"1.26","vol":"1.19"},{"date":"2024-09-30","value":"0.91","vol":"0.87"},{"date":"2024-06-30","value":"0.55","vol":"0.55"},{"date":"2024-03-31","value":"0.21","vol":"0.26"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.15 | 1.26 | 0.91 | 0.55 | 0.21 |
| 行业(次) | 0.26 | 1.19 | 0.87 | 0.55 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-30.92","vol":"-47.52"},{"date":"2024-12-31","value":"12.33","vol":"-9.01"},{"date":"2024-09-30","value":"15.21","vol":"-29.47"},{"date":"2024-06-30","value":"23.51","vol":"-36875.39"},{"date":"2024-03-31","value":"-11.90","vol":"-44804.94"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -30.92 | 12.33 | 15.21 | 23.51 | -11.90 |
| 行业 | -47.52 | -9.01 | -29.47 | -36875.39 | -44804.94 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"3.83","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"2.78","vol":"2.72"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 3.83 | - | 2.78 | - |
| 行业 | 0.00 | 2.00 | 0.00 | 2.72 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 27/72 ， 20/72。
[{"date":"2025-03-31","value":"4.19","vol":"7.90"},{"date":"2024-12-31","value":"3.74","vol":"6.83"},{"date":"2024-09-30","value":"4.06","vol":"7.16"},{"date":"2024-06-30","value":"3.72","vol":"7.04"},{"date":"2024-03-31","value":"4.01","vol":"8.08"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
4.19 | 3.74 | 4.06 | 3.72 | 4.01 |
| 行业 | 7.90 | 6.83 | 7.16 | 7.04 | 8.08 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.37","vol":"6.47"},{"date":"2024-12-31","value":"2.42","vol":"5.50"},{"date":"2024-09-30","value":"2.70","vol":"5.77"},{"date":"2024-06-30","value":"2.45","vol":"5.91"},{"date":"2024-03-31","value":"2.66","vol":"6.93"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.37 | 2.42 | 2.70 | 2.45 | 2.66 |
| 行业 | 6.47 | 5.50 | 5.77 | 5.91 | 6.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 32/72 ， 33/72。
[{"date":"2025-03-31","value":"12.94","vol":"25.48"},{"date":"2024-12-31","value":"14.37","vol":"25.46"},{"date":"2024-09-30","value":"13.57","vol":"24.92"},{"date":"2024-06-30","value":"13.89","vol":"24.62"},{"date":"2024-03-31","value":"13.46","vol":"23.98"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
12.94 | 14.37 | 13.57 | 13.89 | 13.46 |
| 行业(%) | 25.48 | 25.46 | 24.92 | 24.62 | 23.98 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.15","vol":"0.78"},{"date":"2024-12-31","value":"0.17","vol":"0.88"},{"date":"2024-09-30","value":"0.16","vol":"0.41"},{"date":"2024-06-30","value":"0.16","vol":"0.38"},{"date":"2024-03-31","value":"0.16","vol":"0.36"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.15 | 0.17 | 0.16 | 0.16 | 0.16 |
| 行业(%) | 0.78 | 0.88 | 0.41 | 0.38 | 0.36 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 海通国际 | 2025-05-15 | 增持 | |
| 万联证券 | 2025-05-06 | 买入 | |
| 东方证券 | 2025-05-06 | 买入 | |
| 华源证券 | 2025-04-30 | 买入 | |
| 中邮证券 | 2025-04-29 | 买入 | |
| 招商证券 | 2025-04-27 | 增持 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"3.91","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.87","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"7.45","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.93","blueLineValue":"0.94","type":"YC"}]